140
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-β-cyclodextrin

, , , &
Pages 1452-1459 | Received 06 Oct 2008, Accepted 26 Apr 2009, Published online: 20 Nov 2009

References

  • Lee SW, Lim JM, Bhoo SH. (2003). Colorimetric determination of aminoacids using genip in from Gardenia jasminoides. Analytica Chemica Acta, 480:267–74.
  • Cho HJ, Park YS, Kim MG. (2001). Isolation and characterization the major colorant in Gardenia fruit. Dyes Pigments, 49:15–20.
  • Okada K, Shoda J, Kano M, Suzuki S, Ohtake N, Yamamoto M, . (2007). Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediatedcholeresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol, 292:G1450–63.
  • Yang L, Akao T, Kobashi K. (1995). Purification and characterization of a geniposide-hydrolyzing beta-glucosidase from Eubacterium sp. A-44, a strict anaerobe from human feces. Biol Pharm Bull, 18:1175–8.
  • Takeuchi S, Goto T, Mikami K, Miura K, Ohshima S, Yoneyama K, . (2005). Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production. Hepatol Res, 33:298–305.
  • Koo HJ, Lim KH, Jung HJ, Park EH. (2006). Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. J Ethnopharmacol, 103:496–500.
  • Koo HJ, Song YS, Kim HJ, Lee YH, Hong SM, Kim SJ, . (2004). Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol, 495:201–208.
  • Chang Y, Chen SC, Wei HJ, Wu TJ, Liang HC, Lai PH, . (2005). Tissue regeneration observed in a porous acellular bovine pericardium used to repair a myocardial defect in the right ventricle of a rat model. Thorac Cardiovasc Surg, 130:705–711.
  • Kim BC, Kim HG, Lee SA, Lim S, Park EH, Kim SJ, . (2005). Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway. Biochem Pharmacol, 70:1398–407.
  • Inao M, Mochida S, Matsui A, Eguchi Y, Yulutuz Y, Wang Y, . (2004). Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J Hepatol, 41:584–91.
  • Yamazaki M, Sakura N, Chiba K, Mohri T. (2001). Prevention of the neurotoxicity of the amyloid beta protein by genipin. Biol Pharm Bull, 24:1454–5.
  • Suzuki Y, Kondo K, Ikeda Y, Umemura K. (2001). Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med, 67:807–10.
  • Aachmann FL, Otzen DE, Larsen KL, Wimmer R. (2003). Structural background of cyclodextrin-protein interactions. Protein Eng, 16:905–12.
  • Wang JH, Li X., Xu SR. (2007). Characterization of the inclusion complexes of nitrendipine with β-cyclodextrin. J Chongqing Univ (Natural Science Edition), 7:124–29.
  • Loftsson T, Fridriksdottir H, Olafsdottir BJ, Gudmundsson O. (1991). Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharmaceutica Nordica, 3:215–7.
  • Loftsson T, Sigurdsson HH, Masson M, Schipper N. (2004). Preparation solid drug/cyclodextrin complexes of acidic and basic drugs. Pharmazie, 59:25–9.
  • Redenti E, Szente L, Szejtli J. (2000). Drug/cyclodextrin/hydroxy acid multicomponent systems: Properties and pharmaceutical applications. J Pharm Sci, 89:1–8.
  • Buchanan CM, Buchanan NL, Edgar KJ, Lambert JL, Posey-Dowty JD, Ramsey MG, . (2006). Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes. J Pharm Sci, 95:2246–55.
  • Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Malcolm MO, Ruble KM, . (2007). Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifenhydroxybutenyl-beta-cyclodextrin formulations. J Pharm Sci, 96:644–60.
  • Buchanan CM, Buchanan NL, Edgar KJ, Ramsey MG. (2007). Solubility and dissolution studies of antifungal drug: hydroxybutenyl-beta-cyclodextrin complexes. Cellulose, 14:35–47.
  • Buchanan CM, Buchanan NL, Edgar KJ, Klein S, Little JL, Ruble KM, . (2007). Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations. J Pharm Sci, 96:3100–66.
  • Wempe MF, Buchanan CM, Buchanan NL, Edgar KJ, Hanley GA, Ramsey MG, . (2007). Pharmacokinetics of letrozole in male and female rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. J Pharm Pharmacol, 59:795–802.
  • Higuchi T, Connors KA. (1965). Phase solubility techniques. Adv Anal Chem Instrum, 4:117–212.
  • Liu J, Qiu LY, Gao JQ, Jin Y. (2006). Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-β-cyclodextrin. Int J Pharm, 312:137–43.
  • Mura P, Faucci MT, Parrini PL. (2001). Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketofen physicochemical properties. Drug Dev Ind Pharm, 27:119–28.
  • Shigeaki F, Tomoko Y, Kunimasa K, Jun-ichi K. (1987). The continuous hydrolysis of geniposide to genipin using immobilized β-glucosidase on calcium alginate gel. Biotechnol Lett, 9:697–702.
  • Brandao AS, Malheiros TA, Dal Magro A, Filho C, Yunes A. (2003). Characterization of sesquiterpene polygodial-beta cyclodextrin inclusion complex. J Incl Phenom Macro, 46:77–81.
  • Chowdary KP, Nalluri N. (2000). Nimesulide and β-cyclodextrin inclusion complex: Physicochemical characterization and dissolution rate studies. Drug Dev Ind Pharm, 26(11):1217–20.
  • Sri KV, Kondaiah A, Ratna JV, Annapurna A. (2007). Preparation and characterization of quercetin and rutin cyclodextrin inclusion complex. Drug Dev Ind Pharm, 33:245–53.
  • Veiga F, Femandes C, Maincent P. (2001). Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system. Drug Dev Ind Pharm, 27(6):523–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.